Singapore
· Delayed Price · Currency is SGD AJJ Medtech Holdings Statistics
Total Valuation
AJJ Medtech Holdings has a market cap or net worth of SGD 4.51 million. The enterprise value is 6.81 million.
| Market Cap | 4.51M |
| Enterprise Value | 6.81M |
Important Dates
The next estimated earnings date is Wednesday, February 26, 2025.
| Earnings Date | Feb 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AJJ Medtech Holdings has 1.50 billion shares outstanding. The number of shares has increased by 31.12% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.50B |
| Shares Change (YoY) | +31.12% |
| Shares Change (QoQ) | +7.47% |
| Owned by Insiders (%) | 51.31% |
| Owned by Institutions (%) | n/a |
| Float | 700.27M |
Valuation Ratios
| Price/FFO Ratio | n/a |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.45 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.38 |
| EV / Sales | 2.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.69
| Current Ratio | 0.69 |
| Quick Ratio | 0.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -46.48 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 79,219 |
| Profits Per Employee | -89,438 |
| Employee Count | 32 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -50.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 44.65 |
| Average Volume (20 Days) | 411,140 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AJJ Medtech Holdings had revenue of SGD 2.54 million and -2.86 million in losses. Loss per share was -0.00.
| Revenue | 2.54M |
| Gross Profit | 634,000 |
| Operating Income | -2.93M |
| Pretax Income | -2.87M |
| Net Income | -2.86M |
| EBITDA | -2.76M |
| EBIT | -2.93M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 16,000 in cash and 2.20 million in debt, giving a net cash position of -2.18 million or -0.00 per share.
| Cash & Cash Equivalents | 16,000 |
| Total Debt | 2.20M |
| Net Cash | -2.18M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -541,000 |
| Book Value Per Share | -0.00 |
| Working Capital | -900,000 |
Cash Flow
| Operating Cash Flow | -1.32M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 25.01%, with operating and profit margins of -115.50% and -112.90%.
| Gross Margin | 25.01% |
| Operating Margin | -115.50% |
| Pretax Margin | -113.25% |
| Profit Margin | -112.90% |
| EBITDA Margin | -108.68% |
| EBIT Margin | -115.50% |
| FCF Margin | n/a |
Dividends & Yields
AJJ Medtech Holdings does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.12% |
| Shareholder Yield | -31.12% |
| Earnings Yield | -77.90% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |